Mitral valve disease--morphology and mechanisms

Area of Science:

• Cardiovascular Biology
• Translational Medicine
• Molecular Cardiology

Background:

• Mitral valve disease is a primary cause of heart failure and mortality.
• The mitral valve is a dynamic structure, not passive, and amenable to therapeutic intervention.
• Understanding mitral valve plasticity and its role in disease progression is crucial.

Purpose of the Study:

• To explore the dynamic nature of the mitral valve and its therapeutic potential.
• To investigate the molecular and cellular mechanisms underlying mitral valve disease progression.
• To identify novel strategies for improving the clinical outcomes of mitral valve disease.

Main Methods:

• Correlating clinical observations of mitral valve disease with underlying cellular and molecular mechanisms.
• Analyzing genetic mutations associated with mitral valve elongation and prolapse.
• Investigating growth factor signaling, cell migration, and mechanobiological processes.

Main Results:

• Genetic mutations reveal regulation of growth factor and cell migration pathways by structural molecules.
• Mitral valve enlargement can cause left ventricular outflow tract obstruction and is influenced by valvular-ventricular interactions.
• Ischemic conditions lead to leaflet deficiency, causing mitral regurgitation and exacerbating heart failure.

Conclusions:

• The mitral valve's dynamic nature and plasticity offer opportunities for therapeutic intervention.
• Targeting molecular pathways involved in valve development and degeneration can limit disease progression.
• Bridging clinical and basic science research facilitates discovery of new treatments for mitral valve disease.